Michelle Freed
Family · Hayward, CANPI 1710687017
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations.
Across 47 payments — averaging $20.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$163
- Biogen$84
- Lilly USA, LLC$67
- Pfizer$65
- Axsome Therapeutics, Inc.$63
- Merck$58
- plus $476 from 16 others
What the payments were for
- Food & beverage$976100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $163 |
| Biogen | 3 | $84 |
| Lilly USA, LLC | 3 | $67 |
| Pfizer | 3 | $65 |
| Axsome Therapeutics, Inc. | 2 | $63 |
| Merck | 2 | $58 |
| Novo Nordisk | 2 | $56 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $54 |
| Bausch Health US, LLC | 3 | $54 |
| Verity Pharmaceuticals Inc. | 2 | $39 |
| Exact Sciences | 1 | $30 |
| Kyowa Kirin, Inc. | 1 | $30 |
| Johnson & Johnson | 1 | $29 |
| AstraZeneca | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Amgen | 1 | $25 |
| Agios Pharmaceuticals, Inc. | 1 | $22 |
| GSK | 1 | $20 |
| Bayer | 1 | $18 |
| Indivior Inc. | 1 | $18 |
| Fidia Pharma USA Inc. | 1 | $18 |
| Organon | 1 | $10 |
How this compares
$976 in reported general payments places this provider in the 70th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $272 |
| Atorvastatin Calcium | 12 | $165 |
| Azithromycin | 21 | $86 |
| Cephalexin | 15 | $72 |
Paid to pharmacies, not to this prescriber.
Other family in Hayward
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.